Intravenous chaperone treatment of late-stage Alzheimer´s disease (AD) mouse model affects amyloid plaque load, reactive gliosis and AD-related genes
R Y Zhang(Karolinska Institutet), Jan Johansson(Karolinska Institutet), David Brodin(Karolinska Institutet), Makiko Ohshima(Karolinska Institutet), Yu Wang(Capital Medical University), Marianne Schultzberg(Karolinska University Hospital), Antonin Morancé(University of Mons), Gefei Chen(Uppsala University)
Cited by 8
Related Papers
Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state
|Nature Communications|2017|84
Streptavidin-biotin-peroxidase nanocomplex-amplified microfluidics immunoassays for simultaneous detection of inflammatory biomarkers
|Analytica Chimica Acta|2017|69
[The epidemic characteristics and preventive measures of hemorrhagic fever with syndromes in China].
|PubMed|2004|61
Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro
|Communications Biology|2020|57
Interleukin‐4 and Interleukin‐17 are associated with coronary artery disease
|Clinical Cardiology|2023|11